Sotera Health Company (SHC)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 818 | 931 | 1,004 | 1,049 | 1,100 | 1,164 | 1,216 | 1,247 |
| Operating profit | $m | 393 | 441 | ||||||
| Net profit | $m | -39 | 117 | -234 | 51 | 44 | 78 | 163 | 285 |
| EPS reported | $ | 0.27 | 0.57 | ||||||
| Operating cashflow per share | $ | 1.01 | 1.02 | ||||||
| Capex per share | $ | 0.49 | 0.63 | ||||||
| FCF per share | $ | 0.53 | 0.39 | ||||||
| Free cash flow | $m | 149 | 113 | ||||||
| Net debt | $m | 1,803 | 1,783 | ||||||
| Book value equity | $m | 606 | 666 | ||||||
| Book value per share | $ | 2.12 | 2.31 | ||||||
| Number of shares | m | 286.42 | 288.15 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 65.33 | 32.04 | ||||||
| P/B LTM | x | 8.27 | 7.52 | ||||||
| P/S LTM | x | 4.30 | 4.12 | ||||||
| P/FCF LTM | x | 33.58 | 44.44 | ||||||
| EV/EBITDA LTM | x | 15.68 | 12.86 | ||||||
| EV/Sales LTM | x | 5.96 | 6.00 | ||||||
| Earnings Yield LTM | % | +1.53% | +3.12% | ||||||
| FCF Yield | % | +2.98% | +2.25% | ||||||
| Quality | |||||||||
| ROE | % | +12.86% | +26.75% | ||||||
| ROIC | % | +6.83% | +8.80% | ||||||
| Operating margin | % | +33.75% | +36.24% | ||||||
| Gross margin | % | +55.48% | +54.72% | ||||||
| FCF/Sales | % | +12.82% | +9.27% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +68.75% | +256.25% | ||||||
| Sales Growth YoY | % | +5.74% | +10.52% | ||||||
| Net Income Growth YoY | % | +75.57% | +268.21% | ||||||
| FCF Growth | % | +230.81% | +149.93% | ||||||
| Operating Profit Growth | % | +31.97% | +48.08% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.07 | 0.05 | ||||||
| Net Debt/EBITDA | x | 4.36 | 3.54 | ||||||
| EBIT/Net interest | x | 2.52 | 3.07 | ||||||
| Net debt/market cap | % | +42.92% | +39.89% | ||||||
| Net debt/Equity | x | 2.98 | 2.68 | ||||||
| Gross debt/equity | x | 3.75 | 3.41 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free